ArticleJournal of clinical pathology2014

Molecular genetic tests for JAK2V617F, Exon12_JAK2 and MPLW515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasms.

Marcos Tadeu dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.